- Home
- MTVA vs OCC Comparison
MTVA vs OCC Comparison
Compare MTVA & OCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTVA
- OCC
- Stock Information
- Founded
- MTVA 2014
- OCC 1983
- Country
- MTVA United States
- OCC United States
- Employees
- MTVA N/A
- OCC N/A
- Industry
- MTVA
- OCC Telecommunications Equipment
- Sector
- MTVA
- OCC Industrials
- Exchange
- MTVA NYSE
- OCC Nasdaq
- Market Cap
- MTVA 18.9M
- OCC 17.2M
- IPO Year
- MTVA N/A
- OCC 1996
- Fundamental
- Price
- MTVA $1.85
- OCC $2.20
- Analyst Decision
- MTVA
- OCC
- Analyst Count
- MTVA 0
- OCC 0
- Target Price
- MTVA N/A
- OCC N/A
- AVG Volume (30 Days)
- MTVA 256.5K
- OCC 10.2K
- Earning Date
- MTVA 11-07-2024
- OCC 12-27-2024
- Dividend Yield
- MTVA N/A
- OCC N/A
- EPS Growth
- MTVA N/A
- OCC N/A
- EPS
- MTVA N/A
- OCC N/A
- Revenue
- MTVA N/A
- OCC $64,517,697.00
- Revenue This Year
- MTVA N/A
- OCC N/A
- Revenue Next Year
- MTVA N/A
- OCC N/A
- P/E Ratio
- MTVA N/A
- OCC N/A
- Revenue Growth
- MTVA N/A
- OCC N/A
- 52 Week Low
- MTVA $1.55
- OCC $2.02
- 52 Week High
- MTVA $6.75
- OCC $3.53
- Technical
- Relative Strength Index (RSI)
- MTVA N/A
- OCC 40.87
- Support Level
- MTVA N/A
- OCC $2.05
- Resistance Level
- MTVA N/A
- OCC $2.24
- Average True Range (ATR)
- MTVA 0.00
- OCC 0.13
- MACD
- MTVA 0.00
- OCC 0.00
- Stochastic Oscillator
- MTVA 0.00
- OCC 21.05
About MTVA METAVIA INC
MetaVia Inc Formerly NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused predominantly on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. The company has two primary programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH), and obesity. Its product pipeline includes DA-1241 which is a novel G-Protein-Coupled Receptor 119 (GPR119) and DA-1726 which is a novel oxyntomodulin (OXM) analog. The company also has four legacy therapeutics programs designed to impact a range of indications in viral, neurodegenerative, and cardiometabolic diseases: ANA001, NB-01, NB-02, and Gemcabene.
About OCC Optical Cable Corporation
Optical Cable Corp manufactures tight-buffered fiber optic & copper data communication cables, data communication connectivity solutions for enterprise markets, and customized solutions for specialty use & harsh environments. Its products and services include designs and customized products for specialty applications and harsh environments, cabling, connectors, patch cords, assemblies, racks, cabinets, datacom enclosures, patch panels, faceplates, and multi-media boxes. The company supplies its products and services to industries such as the military, industrial, mining, petrochemical, broadcast, oil & gas, and others.